These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19189074)

  • 1. Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy.
    Luedde M; Flögel U; Knorr M; Grundt C; Hippe HJ; Brors B; Frank D; Haselmann U; Antony C; Voelkers M; Schrader J; Most P; Lemmer B; Katus HA; Frey N
    J Mol Med (Berl); 2009 Apr; 87(4):411-22. PubMed ID: 19189074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.
    Wang L; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Kryshtal DO; Knollmann BC
    J Mol Cell Cardiol; 2018 Jan; 114():320-327. PubMed ID: 29217433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias.
    Frey N; Franz WM; Gloeckner K; Degenhardt M; Müller M; Müller O; Merz H; Katus HA
    Cardiovasc Res; 2000 Aug; 47(2):254-64. PubMed ID: 10946062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy.
    Frey N; Brixius K; Schwinger RH; Benis T; Karpowski A; Lorenzen HP; Luedde M; Katus HA; Franz WM
    J Biol Chem; 2006 Oct; 281(40):29575-82. PubMed ID: 16882671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.
    Crilley JG; Boehm EA; Blair E; Rajagopalan B; Blamire AM; Styles P; McKenna WJ; Ostman-Smith I; Clarke K; Watkins H
    J Am Coll Cardiol; 2003 May; 41(10):1776-82. PubMed ID: 12767664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.
    Coppini R; Mazzoni L; Ferrantini C; Gentile F; Pioner JM; Laurino A; Santini L; Bargelli V; Rotellini M; Bartolucci G; Crocini C; Sacconi L; Tesi C; Belardinelli L; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Poggesi C
    Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28255011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T
    Valkovič L; Clarke WT; Schmid AI; Raman B; Ellis J; Watkins H; Robson MD; Neubauer S; Rodgers CT
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):19. PubMed ID: 30871562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
    Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
    J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
    Hernandez OM; Szczesna-Cordary D; Knollmann BC; Miller T; Bell M; Zhao J; Sirenko SG; Diaz Z; Guzman G; Xu Y; Wang Y; Kerrick WG; Potter JD
    J Biol Chem; 2005 Nov; 280(44):37183-94. PubMed ID: 16115869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy.
    Knollmann BC; Blatt SA; Horton K; de Freitas F; Miller T; Bell M; Housmans PR; Weissman NJ; Morad M; Potter JD
    J Biol Chem; 2001 Mar; 276(13):10039-48. PubMed ID: 11113119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction.
    Dass S; Cochlin LE; Suttie JJ; Holloway CJ; Rider OJ; Carden L; Tyler DJ; Karamitsos TD; Clarke K; Neubauer S; Watkins H
    Eur Heart J; 2015 Jun; 36(24):1547-54. PubMed ID: 25990345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins.
    Rust EM; Albayya FP; Metzger JM
    J Clin Invest; 1999 May; 103(10):1459-67. PubMed ID: 10330428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy.
    Vakrou S; Liu Y; Zhu L; Greenland GV; Simsek B; Hebl VB; Guan Y; Woldemichael K; Talbot CC; Aon MA; Fukunaga R; Abraham MR
    Sci Rep; 2021 Jun; 11(1):13163. PubMed ID: 34162896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: a preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation.
    Chen Y; Zhang Z; Hu F; Yang W; Yuan J; Cui J; Hao S; Hu J; Zhou Y; Qiao S
    J Steroid Biochem Mol Biol; 2015 Mar; 147():92-102. PubMed ID: 25541436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational investigation of electrophysiology in hypertrophic cardiomyopathy.
    Flenner F; Jungen C; Küpker N; Ibel A; Kruse M; Koivumäki JT; Rinas A; Zech ATL; Rhoden A; Wijnker PJM; Lemoine MD; Steenpass A; Girdauskas E; Eschenhagen T; Meyer C; van der Velden J; Patten-Hamel M; Christ T; Carrier L
    J Mol Cell Cardiol; 2021 Aug; 157():77-89. PubMed ID: 33957110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action.
    Watkins H; Seidman CE; Seidman JG; Feng HS; Sweeney HL
    J Clin Invest; 1996 Dec; 98(11):2456-61. PubMed ID: 8958207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal energy deprivation underlies arrhythmia susceptibility in mice with calcium-sensitized myofilaments.
    Huke S; Venkataraman R; Faggioni M; Bennuri S; Hwang HS; Baudenbacher F; Knollmann BC
    Circ Res; 2013 May; 112(10):1334-44. PubMed ID: 23532597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy.
    Crocini C; Ferrantini C; Scardigli M; Coppini R; Mazzoni L; Lazzeri E; Pioner JM; Scellini B; Guo A; Song LS; Yan P; Loew LM; Tardiff J; Tesi C; Vanzi F; Cerbai E; Pavone FS; Sacconi L; Poggesi C
    J Mol Cell Cardiol; 2016 Feb; 91():42-51. PubMed ID: 26714042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.